SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001013762-15-000141
Filing Date
2015-02-11
Accepted
2015-02-11 16:38:58
Documents
1
Period of Report
2015-02-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3021115cranston_delmar.html 3  
1 OWNERSHIP DOCUMENT f3021115cranston_delmar.xml 3 3364
  Complete submission text file 0001013762-15-000141.txt   4815
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4316 LOCARNO CRESCENT VANCOUVER A1 V6R 1G3
Business Address
Cranston Lynda Sarah (Reporting) CIK: 0001633660 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54801 | Film No.: 15600076